Literature DB >> 24523506

Cutting edge: IFN-γR signaling in non-T cell targets regulates T cell-mediated intestinal inflammation through multiple mechanisms.

Jeong-su Do1, Kewal Asosingh, William M Baldwin, Booki Min.   

Abstract

Naive CD4 T cells transferred into lymphopenic mice undergo spontaneous proliferation and induce chronic inflammation in the intestine. Cellular mechanisms regulating the proliferative and inflammatory processes are not fully understood. In this study, we report that IFN-γ signaling in host cells plays a major role in limiting both T cell expansion and T cell-induced intestinal inflammation. However, the role of IFN-γ appears to differ depending on the target cells. IFN-γ signaling in dendritic cells controls T cell expansion, whereas IFN-γ signaling in neutrophils seems to regulate both T cell expansion and inflammation. IFN-γ signaling in nonhematopoietic cells may control inflammation. Therefore, our results suggest novel immunoregulatory functions for IFN-γ to orchestrate colitogenic T cell responses through its distinct action on different non-T cell target cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24523506      PMCID: PMC3951657          DOI: 10.4049/jimmunol.1303101

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

Authors:  Ivan D Mascanfroni; Ada Yeste; Silvio M Vieira; Evan J Burns; Bonny Patel; Ido Sloma; Yan Wu; Lior Mayo; Rotem Ben-Hamo; Sol Efroni; Vijay K Kuchroo; Simon C Robson; Francisco J Quintana
Journal:  Nat Immunol       Date:  2013-09-01       Impact factor: 25.606

2.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

3.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

Review 4.  Nitric oxide and T helper cell immunity.

Authors:  R C van der Veen
Journal:  Int Immunopharmacol       Date:  2001-08       Impact factor: 4.932

5.  The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells.

Authors:  Chi-Keung Wan; Jangsuk Oh; Peng Li; Erin E West; Elizabeth A Wong; Allison B Andraski; Rosanne Spolski; Zu-Xi Yu; Jianping He; Brian L Kelsall; Warren J Leonard
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

6.  IFN-gamma-inducible chemokines enhance adaptive immunity and colitis.

Authors:  Udai P Singh; Shailesh Singh; Nuzhat Iqbal; Casey T Weaver; Jerry R McGhee; James W Lillard
Journal:  J Interferon Cytokine Res       Date:  2003-10       Impact factor: 2.607

Review 7.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

8.  IFN-γ protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils.

Authors:  Carine Savarin; Stephen A Stohlman; David R Hinton; Richard M Ransohoff; Daniel J Cua; Cornelia C Bergmann
Journal:  J Neuroinflammation       Date:  2012-05-29       Impact factor: 8.322

9.  IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.

Authors:  A Visperas; J S Do; K Bulek; X Li; B Min
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

10.  Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation.

Authors:  Thibault Griseri; Brent S McKenzie; Chris Schiering; Fiona Powrie
Journal:  Immunity       Date:  2012-11-29       Impact factor: 31.745

View more
  7 in total

1.  cEBP Homologous Protein Expression in Macrophages Regulates the Magnitude and Duration of IL-6 Expression and Dextran Sodium Sulfate Colitis.

Authors:  Shyamasree Datta; Natilibeth Barrera; Paul G Pavicic; Chenyang Zhao; Michael Freeman; Booki Min; Thomas Hamilton
Journal:  J Interferon Cytokine Res       Date:  2015-07-02       Impact factor: 2.607

2.  T lymphocytes control microbial composition by regulating the abundance of Vibrio in the zebrafish gut.

Authors:  Sylvia Brugman; Kerstin Schneeberger; Merlijn Witte; Mark R Klein; Bartholomeus van den Bogert; Jos Boekhorst; Harro M Timmerman; Marianne L Boes; Michiel Kleerebezem; Edward E S Nieuwenhuis
Journal:  Gut Microbes       Date:  2014

3.  Immune Characters and Plasticity of the Sentinel Lymph Node in Colorectal Cancer Patients.

Authors:  Xiaoyun Li; Jingling Tang; Hang Du; Xinjun Wang; Liyun Wu; Pingsheng Hu; Hua Zhang; Ruyi Zhang; Yuan Yang
Journal:  J Immunol Res       Date:  2021-08-18       Impact factor: 4.818

4.  Spontaneous proliferation of H2M-/- CD4 T cells results in unusual acute hepatocellular necrosis.

Authors:  Jeong-su Do; William M Baldwin; Booki Min
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

5.  Pathophysiological roles of cytokine-chemokine immune network.

Authors:  Jong-Young Kwak; Mizuko Mamura; Jana Barlic-Dicen; Evelin Grage-Griebenow
Journal:  J Immunol Res       Date:  2014-09-11       Impact factor: 4.818

Review 6.  Cellular factors targeting APCs to modulate adaptive T cell immunity.

Authors:  Anabelle Visperas; Jeongsu Do; Booki Min
Journal:  J Immunol Res       Date:  2014-07-14       Impact factor: 4.818

7.  Interferon-γ Receptor Signaling in Dendritic Cells Restrains Spontaneous Proliferation of CD4+ T Cells in Chronic Lymphopenic Mice.

Authors:  Laura Knop; Charlotte Frommer; Diana Stoycheva; Katrin Deiser; Ulrich Kalinke; Thomas Blankenstein; Thomas Kammertoens; Ildiko Rita Dunay; Thomas Schüler
Journal:  Front Immunol       Date:  2019-02-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.